Large artery stiffness and inflammation

Journal of Human Hypertension

Volumn 19, Issue 7, 2005, Pages 507-509

  McEniery, C M ^a   Wilkinson, I B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; GELATINASE B; INTERLEUKIN 6; NITRIC OXIDE; PROTEOGLYCAN;

ARTERY COMPLIANCE; ATHEROMA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; DISEASE MODEL; DISEASE PREDISPOSITION; ENDOTHELIUM LESION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; NONHUMAN; NOTE; PATHOPHYSIOLOGY; RHEUMATOID ARTHRITIS; SYSTEMIC VASCULITIS;

ANIMALS; ARTERITIS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; ELASTICITY; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; MUSCLE, SMOOTH, VASCULAR;

EID: 21744434952     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001814     Document Type: Note

References (37)

1. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
2. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003; 169: 203-214.
3. Liuzzo G et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994; 331: 417-424.
4. Ridker PM et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1998; 98: 839-844.
5. Ridker PM et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979.
6. Ridker PM et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-1565.
7. Luscher TF. The Endothelium in Cardiovascular Disease. Springer-verlag: New York, 1995.
8. Suwaidi JA et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948-954.
9. Perticone F et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104: 191-196.
10. Fichtlscherer S et al. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000; 102: 1000-1006.
11. Hingorani AD et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 2000; 102: 994-999.
12. Kharbanda RK et al. Prevention of inflammation-induced endothelial dysfunction: a novel vasculoprotective action of aspirin. Circulation 2002; 105: 2600-2604.
13. Booth AD et al. Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation. Circulation 2004; 109: 1718-1723.
14. Filer AD et al. Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa. Ann Rheum Dis 2003; 62: 162-167.
15. Hurlimann D et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 2002; 106: 2184-2187.
16. Bergholm R et al. Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Arterioscler Thromb Vasc Biol 2002; 22: 1637-1641.
17. Solomon DH et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003; 107: 1303-1307.
18. Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor. Am J Epidemiol 1994; 140: 669-682.
19. Blacher J et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439.
20. Laurent S et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
21. Meaume S et al. Aortic pulse wave velocity predicts cardiovascular mortality in subjects > 70 years of age. Arterioscler Thromb Vasc Biol 2001; 21: 2046-2050.
22. Cruickshank K et al. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002; 106: 2085-2090.
23. London GM et al. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001; 38: 434-438.
24. Glasser SP et al. Vascular compliance and cardiovascular disease: a risk factor or a marker? Am J Hypertens 1997; 10: 1175-1189.
25. Abramson JL, Weintraub WS, Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension 2002; 39: 197-202.
26. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension 2001; 38: 399-403.
27. London GM et al. Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients. Kidney Int Suppl 2003; 84: 88-93.
28. Booth AD et al. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum 2004; 50: 581-588.
29. Yasmin, McEniery CM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkinson IB. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 2004; 24: 969-974.
30. Okamura T et al. Non-invasive measurement of brachial-ankle pulse wave velocity is associated with serum C-reactive protein but not with alpha-tocopherol in Japanese middle-aged male workers. Hypertens Res 2004; 27: 173-180.
31. Mattace-Raso FU et al. C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. Atherosclerosis 2004; 176: 111-116.
32. Duprez D et al. Relationship between C-reactive protein and arterial stiffness in an asymptomatic population. J Hum Hypertens 2005; 19: 515-519.
33. Wilkinson IB et al. Nitric oxide regulates local arterial distensibility in vivo. Circulation 2002; 105: 213-217.
34. McEniery CM et al. Endothelin-1 regulates arterial pulse wave velocity in vivo. J Am Coll Cardiol 2003; 42: 1975-1981.
35. Schmitt M et al. Role of natriuretic peptides in regulation of conduit artery distensibility. Am J Physiol Heart Circ Physiol 2004; 287: H1167-H1171.
36. The Molecular Biology and Pathology of Elastic Tissues. John Wiley & Sons: Chichester, 1995.
37. Floege J, Ketteler M. Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant 2004; 19(Suppl 5): V59-V66.